MEGAN WEBB: Open Payments
NPI 1821506817 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 31 payments from 11 companies in 2025. Trend: 2023 $129 · 2024 $502 · 2025 $706
Food & beverage: $706
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $303 |
| Tandem Diabetes Care, Inc. | 4 | $94 |
| Lilly USA, LLC | 6 | $91 |
| Corcept Therapeutics | 2 | $48 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $48 |
| PolyNovo North America LLC | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Antares Pharma, Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $19 |
| Abbott Laboratories | 1 | $18 |
Products named: Wegovy, t:slim X2 Insulin Pump with Control-IQ, MOUNJARO, Ozempic, Korlym, ISTURISA, NOVOSORB BTM, JARDIANCE.
Industry payments across AR — which companies pay providers there.
